Short piece in Bioshares 712

  1. 1,032 Posts.
    lightbulb Created with Sketch. 145
    Bioshares wrote a short piece on BNO. Rated a speculative buy (class A) but importantly gave a summary table of competing PhII studies and expected completion date. The publication says it will review the programs in a future issue. It also mentioned the strategy to get out of oncology. I'll keep my eye open for the next 'review' piece. Meanwhile the SP is tracking nicely and the analysts' reports are all positive also. GLTA
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.